Physicians' Persistence and Its Implications for Their Response to Promotion of Prescription Drugs

References

• Abbasi K., Smith R. No more free lunches. British Medical J. (2003) 326:1155–1156Crossref, Google Scholar
• Alexander C., Tseng C. Six strategies to identify and assist patients burdened by out-of-pocket prescription costs? Cleveland Clinic J. Medicine (2004) 71(5):433–437Crossref, Google Scholar
• Alvanzo A. H., Cohen G. M., Nettleman M. Changing physician behavior: Half-empty or half-full? Clinical Governance: An Internat. J. (2003) 8(1):69–78Crossref, Google Scholar
• Baker D., Rosnick D. The burden of social security taxes and the burden of excessive health care costs. (2005) . Report, Center for Economic and Policy Research, Washington, D.C. Retrieved November 7, 2006, http://www.cepr.netGoogle Scholar
• Bauer R. A., Wortzel L. H. Doctor's choice: The physician and his sources of information. J. Marketing Res. (1966) 3(1):40–46Crossref, Google Scholar
• Berndt E. R., Bui L. T., Lucking-Reiley D. H., Urban G. L., Bresnahan T. F., Gordon R. J. The roles of marketing, product quality, and price competition in the growth and competition of the U.S. antiulcer drug industry. The Economics of New Goods (1997) (University of Chicago Press, Chicago) 277–232Google Scholar
• Berwick D. M. Disseminating innovations in health care. J. Amer. Medical Assoc. (2003) 289(April):1969–1975Crossref, Google Scholar
• Bhat C. Quasi-random maximum simulated likelihood estimation of the mixed multinomial logit model. Transportation Res. B (2001) 35:677–693Crossref, Google Scholar
• Choudhry N. K., Fletcher R. H., Soumerai S. B. Systematic review: The relationship between clinical experience and quality of health care. Amer. College Physicians (2005) 142(4):260–273Google Scholar
• Coleman J. S., Katz E., Menzel H.Medical Innovation: A Diffusion Study (1966) (The Bobbs-Merrill Company, Indianapolis) Google Scholar
• Connelly D. P., Rich E. C., Curley S. P., Kelly J. T. Knowledge resource preferences of family physicians. J. Family Practice (1990) 30(3):353–359Google Scholar
• Coscelli A. The importance of doctors' and patients' preferences in the prescription decision. J. Indust. Econom. (2000) 48(3):349–369Crossref, Google Scholar
• Danzon P. M., Furukawa M. Health care: Competition and productivity. The Economic Payoff from the Internet Revolution (2001) (Brookings Institution Press, Washington, D.C.) 189–234The Brookings Task Force on the InternetGoogle Scholar
• Dekimpe M. G., Hanssens D. H. The persistence of marketing effects on sales. Marketing Sci. (1995) 14(1):1–21Link, Google Scholar
• Dekimpe M. G., Hanssens D. H. Sustained spending and persistent response: A new look at long-term marketing profitability. J. Marketing Res. (1999) 36(November):397–412Crossref, Google Scholar
• Erdem T., Sun B. Testing for choice dynamics in panel data. J. Bus. Econom. Statist. (2001) 19(2):142–152Crossref, Google Scholar
• Freiman M. P. The rate of adoption of new procedures among physicians: The impact of specialty and practice characteristics. Medical Care (1985) 23:939–945Crossref, Google Scholar
• Gönül F., Carter F., Petrova E., Srinivasan K. Promotion of prescription drugs and its impact on physicians' choice behavior. J. Marketing (2001) 65:79–90Crossref, Google Scholar
• Gorman P. N. Information needs of physicians. J. Amer. Soc. Inform. Sci. (1995) 46:729–736Crossref, Google Scholar
• Greene W. H.Econometric Analysis (2003) 5th ed.(Prentice Hall, Upper Saddle River, NJ) Google Scholar
• Hall W. The ethical dilemma of accepting gifts from drug makers. (2001) . ACP-ASIM Observer (December), http://www.acponline.org/journals/news/dec01/president.htmGoogle Scholar
• Heckman J. J., Rosen S. Heterogeneity and state dependence. Studies in Labor Markets (1981) (University of Chicago Press, Chicago) 91–140Google Scholar
• Hellerstein J. K. The importance of the physician in the generic versus trade-name prescription decision. RAND J. Econom. (1998) 29(1):108–136Crossref, Google Scholar
• Hlatky M. A., Cotugno H., O'Connor C., Mark D. B., Pryor D. B., Califf R. M. Adoption of thrombolytic therapy in the management of acute myocardial infarction. Amer. J. Cardiology (1988) 61:510–514Crossref, Google Scholar
• Kamakura A. W., Russell G. J. A probabilistic choice model for market segmentation and elasticity structure. J. Marketing Res. (1989) 26(2):379–390Crossref, Google Scholar
• Keane M. K. Modeling heterogeneity and state dependence in consumer choice behavior. J. Bus. Econom. Statist. (1997) 15(3):310–327Crossref, Google Scholar
• Klemperer P. Markets with consumer switching costs. Quart. J. Econom. (1987) 102:375–394Crossref, Google Scholar
• Laine C., Weinberg D. S. How can physicians keep up-to-date? Annual Rev. Medicine (1999) 50:99–110Crossref, Google Scholar
• Manchanda P., Chintagunta P. K. Responsiveness of physician prescription behavior to salesforce effort: An individual level analysis. Marketing Lett. (2004) 15(2–3):129–145Crossref, Google Scholar
• Manchanda P., Rossi P. E., Chintagunta P. K. Response modeling with non-random marketing mix variables. J. Marketing Res. (2004) 41(November):467–478Crossref, Google Scholar
• McFadden D., Zarembka P. Conditional logit analysis of qualitative choice behavior. Frontiers in Econometrics (1973) (Academic Press, New York) 105–142Google Scholar
• McFadden D., Train K. Mixed MNL models for discrete responses. J. Appl. Econometrics (2000) 15(5):447–470Crossref, Google Scholar
• Meyers-Levy J. The influence of sex roles in judgment. J. Consumer Res. (1988) 14:522–530Crossref, Google Scholar
• Meyers-Levy J., Sternthal B. Gender differences in the use of message cues and judgments. J. Marketing Res. (1991) 28(1):84–96Crossref, Google Scholar
• Mizik N., Jacobson R. Are physicians easy marks? Quantifying the effects of detailing and sampling on new prescriptions. Management Sci. (2004) 50(12):1704–1715Link, Google Scholar
• Mottur-Pilson C., Snow V., Bartlett K. Physician explanations for failing to comply with best practices. Effective Clinical Practice (2001) 4:207–213Google Scholar
• Narayanan S., Manchanda P., Chintagunta P. K. Temporal differences in the role of marketing communication in new product categories. J. Marketing Res. (2005) XLII(3):278–290Crossref, Google Scholar
• Nerlove M., Arrow K. J. Optimal advertising policy under dynamic conditions. Economica (1962) 29:129–142Crossref, Google Scholar
• New York Times Merck is said to limit perks in marketing to physicians. (2002a) January 18):C1Google Scholar
• New York Times Vermont to require drug makers to disclose payments to doctors. (2002b) June 13):C1Google Scholar
• Pauker S. D., Gorry G., Kassirer J., Schwartz W. Towards the simulation of clinical cognition: Taking a present illness by computer. Amer. J. Med. (1976) 60(7):981–996Crossref, Google Scholar
• Phillips L. S., Branch W. T., Cook C. B., Doyle J. P., El-Kebbi I. M., Gallina D. L., Miller C. D., Ziemer D. C., Barnes C. S. Clinical inertia. Ann. Internat. Med. (2001) 135(November):825–834Crossref, Google Scholar
• Richard O., Van Horn L. Persistence in prescriptions of branded drugs. Internat. J. Indust. Organ. (2003) 22:523–540Crossref, Google Scholar
• Seetharaman P. B., Ainslie A., Chintagunta P. K. Investigating household state dependence effects across categories. J. Marketing Res. (1999) 36(4):488–500Crossref, Google Scholar
• Shaughnessy A. F., Slawson D. C. Pharmaceutical representatives. British Medical J. (1996) 312(JuneGoogle Scholar
• Shugan S. The cost of thinking. J. Consumer Res. (1980) 7(2):99–111Crossref, Google Scholar
• Smith R. Information in practice: What clinical information do doctors need? British Medical J. (1996) 313(October):1062–1068Crossref, Google Scholar
• Spilker B. The benefits and risks of a pack of M&M's: A pharmaceutical spokesman answers his industry's critics. Health Affairs (2002) 21(2):243–244Crossref, Google Scholar
• Stern S., Trajtenberg M. Empirical implications of physician authority in pharmaceutical decision making. (1998) . Working Paper 6851, National Bureau of Economic Research, Cambridge, MACrossref, Google Scholar
• Telegraph Are GPs in thrall to the drug companies? (2005) February 23Google Scholar
• Train K.Discrete Choice Methods with Simulation (2003) (Cambridge University Press, New York) Crossref, Google Scholar
• Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? J. Amer. Medical Assoc. (2000) 283(January):373–380Crossref, Google Scholar
• Williamson J. W., German P. S., Weiss R., Skinner E. A., Bowes F. Health science information management and continuing education of physicians: A survey of U.S. primary care practitioners and their opinion leaders. Ann. Internat. Med. (1989) 110:151–160Crossref, Google Scholar
• Wittink R. D. Analysis of ROI for pharmaceutical promotions. (2002) . Unpublished study conducted for the Association of Medical Publications. Retrieved May 4, 2007, http://www.rxpromoroi.org/arpp/index.htmlGoogle Scholar
• Wyatt J. Uses and sources of medical knowledge. Lancet (1991) 338:1368–1372Crossref, Google Scholar
• Young M. J., Fried L. S., Eisenberg J., Hershey J., Williams S. Do cardiologists have higher thresholds for recommending coronary arteriography than family physicians? Health Serv. Res. (1987) 22(5):623–635Google Scholar